Purpose ApneaLink is a portable device for the screening of sleep apnea, a prevalent and
underdiagnosed comorbidity in heart failure patients. A prospective cross-sectional study in …

Background Sleep apnea is an important comorbidity in heart failure (HF) and is associated
with an adverse outcome. Diagnosing sleep apnea is difficult, and polysomnography …

Background Sleep apnea is an underdiagnosed condition in patients with heart failure.
Efficient identification of sleep apnea is needed, as treatment may improve heart failure …

Study Objectives: To evaluate home sleep apnea testing (HSAT) using a type 3 portable
monitor to help diagnose sleep-disordered breathing (SDB) and identify respiratory events …

Introduction Central sleep apnea (CSA) is a common and serious comorbidity mainly
occurring in patients with heart failure (HF), which tends to be underdiagnosed and has not …

Introduction Sleep apnea is widely reported as an independent predictor for the
development of heart failure (HF), with a 2.6-fold increase in incidence after adjusting for …

Introduction: Sleep-disordered breathing (SDB) is highly prevalent in hospitalized patients
with congestive heart failure (CHF) and the condition is diagnosed and treated in only a …

Untreated sleep disorders form a risk of coronary artery disease, hypertension, obesity, and
diabetes mellitus. Access to polysomnography is limited, especially during the COVID-19 …

Aims At least 50% of patients with heart failure (HF) may have sleep‐disordered breathing
(SDB). Overnight in‐hospital polysomnography (PSG) is considered the gold standard for …

Sleep disorders are a common concomitant comorbidity in patients with heart failure. The
aims of our study are to determine the incidence and phenotypic characteristics of sleep …